Baxter International (BAX) Other Non-Current Liabilities (2009 - 2026)
Baxter International's (BAX) quarterly Other Non-Current Liabilities came in at $1.3 billion in Q1 2026, up 15.15% year-on-year from $1.1 billion in Q1 2025, and little changed on a QoQ basis from $1.3 billion in Q4 2025.
Baxter International (BAX) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Other Non-Current Liabilities data on file, last reported at $1.3 billion in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 15.15% year-over-year to $1.3 billion in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 15.15% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 19.61% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.3 billion, roughly flat from $1.3 billion in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for BAX reached as high as $2.4 billion in Q1 2022 and fell as low as $1.1 billion in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2024.
- Across the five-year window, Other Non-Current Liabilities jumped 48.78% in 2022 and sank 32.08% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $1.8 billion in 2022, then dropped by 24.24% to $1.4 billion in 2023, then decreased by 23.14% to $1.1 billion in 2024, then increased by 19.61% to $1.3 billion in 2025, then grew by 0.39% to $1.3 billion in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.29 Bn |
| Dec 31, 2025 | 1.29 Bn |
| Sep 30, 2025 | 1.12 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.26 Bn |
| Jun 30, 2024 | 1.60 Bn |
| Mar 31, 2024 | 1.65 Bn |
| Dec 31, 2023 | 1.40 Bn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 1.62 Bn |
| Mar 31, 2023 | 1.85 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Sep 30, 2022 | 2.07 Bn |
| Jun 30, 2022 | 2.26 Bn |
| Mar 31, 2022 | 2.43 Bn |
| Dec 31, 2021 | 2.49 Bn |
| Sep 30, 2021 | 1.62 Bn |
| Jun 30, 2021 | 1.62 Bn |